Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Feb 13, 2024

SELL
$2.97 - $8.6 $2,675 - $7,748
-901 Reduced 25.41%
2,645 $8,000
Q3 2023

Nov 14, 2023

SELL
$4.8 - $9.92 $8,635 - $17,846
-1,799 Reduced 33.66%
3,546 $19,000
Q2 2023

Aug 21, 2023

BUY
$8.11 - $10.54 $43,347 - $56,336
5,345 New
5,345 $50,000
Q2 2022

Aug 15, 2022

SELL
$2.23 - $7.81 $6,232 - $21,828
-2,795 Closed
0 $0
Q1 2022

May 16, 2022

BUY
$7.03 - $17.29 $19,648 - $48,325
2,795 New
2,795 $20,000

Others Institutions Holding VIGL

About Vigil Neuroscience, Inc.


  • Ticker VIGL
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 28,268,600
  • Market Cap $62.2M
  • Description
  • Vigil Neuroscience, Inc., a microglia-focused company, engages in the development of disease-modifying therapeutics for patients, caregivers, and families affected by rare and common neurodegenerative diseases. Its lead product candidate is VGL101, a fully human monoclonal antibody (mAb) that is designed to activate triggering receptor expressed...
More about VIGL
Track This Portfolio

Track California State Teachers Retirement System Portfolio

Follow California State Teachers Retirement System and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of California State Teachers Retirement System, based on Form 13F filings with the SEC.

News

Stay updated on California State Teachers Retirement System with notifications on news.